These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2188506)

  • 21. Independence of salt intake induced by calcium deprivation from the renin-angiotensin-aldosterone system.
    Tordoff MG; Pilchak DM; Hughes RL
    Am J Physiol; 1993 Mar; 264(3 Pt 2):R492-9. PubMed ID: 8457002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal renal sodium excretion in the nephrotic syndrome after furosemide: relation to glomerular filtration rate.
    Danielsen H; Pedersen EB; Madsen M; Jensen T
    Acta Med Scand; 1985; 217(5):513-8. PubMed ID: 4025007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of spironolactone treatment on the renin-aldosterone system during pregnancy.
    Lammintausta R; Erkkola R
    Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):294-8. PubMed ID: 489194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.
    Wenzl HH; Fine KD; Santa Ana CA; Porter JL; Fordtran JS
    Dig Dis Sci; 1997 Jan; 42(1):119-28. PubMed ID: 9009126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of potassium loading on sodium excretion and plasma renin activity in Addisonian man.
    Miller PD; Waterhouse C; Owens R; Cohen E
    J Clin Invest; 1975 Aug; 56(2):346-53. PubMed ID: 1150875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma corticosteroid concentrations during spironolactone administration: evidence for adrenal biosynthetic blockade in man.
    Tuck ML; Sowers JR; Fittingoff DB; Fisher JS; Berg GJ; Asp ND; Mayes DM
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1057-61. PubMed ID: 6262360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is the renal dopamine involved in the sodium retention in the nephrotic syndrome?].
    Hou FF; Zhang X
    Zhonghua Nei Ke Za Zhi; 1992 Sep; 31(9):552-5, 587. PubMed ID: 1303850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.
    Millar JA; Fraser R; Mason P; Leckie B; Cumming AM; Robertson JI
    Br J Clin Pharmacol; 1984 Sep; 18(3):369-75. PubMed ID: 6386025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrelated effects of aldosterone and plasma potassium on potassium excretion.
    Young DB; Paulsen AW
    Am J Physiol; 1983 Jan; 244(1):F28-34. PubMed ID: 6849383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma atrial natriuretic peptide and natriuretic response to water immersion in patients with nephrotic syndrome.
    Hwang SJ; Tsai JH; Lai YH; Chen JH
    Nephron; 1991; 58(3):330-8. PubMed ID: 1832746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of the control of plasma aldosterone concentration in normal man. 3. Response to sodium chloride infusion.
    Williams GH; Tuck ML; Rose LI; Dluhy RG; Underwood RH
    J Clin Invest; 1972 Oct; 51(10):2645-52. PubMed ID: 5056660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of spironolactone on the renin-aldosterone system in rats.
    Jiménez W; Martínez-Pardo A; Arroyo V; Gaya J; Rivera F
    Rev Esp Fisiol; 1988 Sep; 44(3):257-63. PubMed ID: 3068736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between aldosterone and bradykinin.
    Mersey JH; Williams GH; Hollenberg NK; Dluhy RG
    Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on renin-angiotensin-aldosterone system. II. Changes of plasma renin activity, plasma aldosterone concentration and urinary sodium excretion in the hypertensives].
    Kawamata A
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):233-42. PubMed ID: 6379238
    [No Abstract]   [Full Text] [Related]  

  • 37. The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II.
    Düsing R; Vetter H; Kramer HJ
    Nephron; 1980; 25(4):187-92. PubMed ID: 6990285
    [No Abstract]   [Full Text] [Related]  

  • 38. Mild potassium depletion provokes renal sodium retention.
    Krishna GG; Chusid P; Hoeldtke RD
    J Lab Clin Med; 1987 Jun; 109(6):724-30. PubMed ID: 3585146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of alterations of sodium intake in patients with hyporeninemic hypoaldosteronism.
    Perez GO; Lespier LE; Oster JR; Vaamonde CA
    Nephron; 1977; 18(5):259-65. PubMed ID: 865654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.